Catalyst Pharmaceuticals Inc (CPRX)
16.44
+0.32 (+1.99%)
USD |
NASDAQ |
Mar 27, 16:00
16.59
+0.15 (+0.91%)
After-Hours: 18:25
Catalyst Pharmaceuticals Free Cash Flow (Quarterly): 40.08M for Dec. 31, 2022
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 40.08M |
| September 30, 2022 | 41.30M |
| June 30, 2022 | 26.16M |
| March 31, 2022 | 8.478M |
| December 31, 2021 | 19.14M |
| September 30, 2021 | 21.64M |
| June 30, 2021 | 15.67M |
| March 31, 2021 | 2.903M |
| December 31, 2020 | 13.10M |
| September 30, 2020 | 11.44M |
| June 30, 2020 | 13.26M |
| March 31, 2020 | 7.213M |
| December 31, 2019 | 12.29M |
| September 30, 2019 | 16.26M |
| June 30, 2019 | 14.06M |
| March 31, 2019 | -8.022M |
| December 31, 2018 | -8.408M |
| September 30, 2018 | -6.976M |
| June 30, 2018 | -4.774M |
| March 31, 2018 | -6.081M |
| December 31, 2017 | -4.030M |
| September 30, 2017 | -2.633M |
| June 30, 2017 | -3.201M |
| March 31, 2017 | -3.879M |
| December 31, 2016 | -4.419M |
| Date | Value |
|---|---|
| September 30, 2016 | -3.278M |
| June 30, 2016 | -4.432M |
| March 31, 2016 | -5.930M |
| December 31, 2015 | -4.631M |
| September 30, 2015 | -5.358M |
| June 30, 2015 | -4.247M |
| March 31, 2015 | -3.803M |
| December 31, 2014 | -3.994M |
| September 30, 2014 | -3.566M |
| June 30, 2014 | -2.997M |
| March 31, 2014 | -2.442M |
| December 31, 2013 | -4.130M |
| September 30, 2013 | -1.684M |
| June 30, 2013 | -1.812M |
| March 31, 2013 | -2.259M |
| December 31, 2012 | -1.639M |
| September 30, 2012 | -1.101M |
| June 30, 2012 | -1.146M |
| March 31, 2012 | -1.306M |
| December 31, 2011 | -1.44M |
| September 30, 2011 | -1.253M |
| June 30, 2011 | -1.465M |
| March 31, 2011 | -0.8311M |
| December 31, 2010 | -0.7692M |
| September 30, 2010 | -0.8173M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.408M
Minimum
Dec 2018
41.30M
Maximum
Sep 2022
11.44M
Average
12.70M
Median
Free Cash Flow (Quarterly) Benchmarks
| ADMA Biologics Inc | -11.13M |
| Ardelyx Inc | 14.28M |
| Rhythm Pharmaceuticals Inc | -34.00M |
| Merrimack Pharmaceuticals Inc | -0.185M |
| Jaguar Health Inc | -8.585M |